Related Experiment Video
Updated: Jun 16, 2026
08:39
Stereotaxic Injection of a Viral Vector for Conditional Gene Manipulation in the Mouse Spinal Cord
Published on: March 18, 2013
Viral vector-mediated gene transfer for CNS disease.
Brooke R Snyder1, Nicholas M Boulis, Thais Federici
1Neurosurgery, Emory University, 101 Woodruff Circle, Atlanta, GA 30322, USA.
Expert Opinion on Biological Therapy
|February 6, 2010
Summary
Gene therapy offers a promising approach for neurological disorders. Advances in viral vector technology enhance safety and delivery, though CNS delivery remains a challenge.
Area of Science:
- Neuroscience
- Genetics
- Medical Research
Background:
- Gene therapy presents a potential treatment for neurological disorders with limited options.
- Recent advancements in viral vectorology and engineering have enhanced safety and delivery efficiency.
Purpose of the Study:
- To review the current status of viral vector development and clinical applications for neurological disorders.
- To discuss delivery routes and ongoing clinical trials in the field.
Main Methods:
- Review of current literature on viral vector development.
- Analysis of delivery methods for the central nervous system (CNS).
- Examination of clinical trial data for gene therapy in neurological conditions.
Main Results:
- Viral vectors can be delivered directly or remotely to the CNS.
- Delivery to the CNS is dependent on disease characteristics and vector tropism.
- Effective gene transfer to the CNS is significantly limited by delivery challenges.
Conclusions:
- Current gene therapy trials primarily focus on gene replacement and neuroprotection.
- The field is evolving towards novel strategies like neuromodulation and gene silencing.
